Superficial bladder tumours: Recurrence and progression

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 3, 2011, Pages 157-160

  Mansoor, Muhammad ^a   Ali, Shahzad ^a   Fasihuddin, Qazi ^a   Baloch, Muhammad Umar ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

Clinical presentation; Progression; Recurrence; Superficial bladder cancer; Transitional cell carcinoma

Indexed keywords

MITOMYCIN C;

ADULT; ARTICLE; BLADDER TUMOR; BONE METASTASIS; CANCER GRADING; CANCER STAGING; CLINICAL ASSESSMENT; CYSTECTOMY; CYSTOSCOPY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEMATURIA; HIGH RISK PATIENT; HUMAN; LOWER URINARY TRACT SYMPTOM; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; PATIENT COMPLIANCE; PELVIS; SUPERFICIAL BLADDER TUMOR; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAKISTAN; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NEOPLASMS;

EID: 79952354166     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Greenlee RT, Murray T, Bolden S, Wing PA. Cancer statistics. Cancer J Clin 2000; 50:7.
2. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasm of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22:1435-48.
3. Young RH, Wick MR, Mills SE. Sarcomatoid carcinoma of the urinary bladder. A clinicopathologic analysis of 12 cases and review of the literature. Am J Clin Pathol 1988; 90:653-61.
4. Ro JY, Staeke GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am 1992; 19:435-53.
5. Kitamura H, Tsukamoto T. Early bladder cancer: concept, diagnosis, and management. Int J Clin Oncol 2006; 11:28-37.
6. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992; 326:737-40. Comment in: p. 759-61.
7. Hinotsu S, Akaza H, Ohashi Y, Kotaka T. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function. Cancer 1999; 86:1818-26.
8. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163:73-8. Comment in: p. 79-80.
9. Lamm DL. Carcinoma in situ. Urol Clin North Am 1992; 19: 499-508.
10. Yang TB, Zeng FH, Sun ZQ. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Chin Med J 2006; 119:1821-8.
11. Donat SM. Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am 2003; 10:765-76.
12. Schulze M, Stotz N, Rassweiler J. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. J Endourol 2007; 21:1533-41.
13. Ahmed Z, Muzaffer S, Khan M, Kayani N, Pervez S, Husseini AS, et al. Transitional cell carcinoma of the urinary bladder: a histopathological study. J Pak Med Assoc 2002; 52:396-8.
14. Roohullah, Nusrat J, Hamdani SR, Burdy GM, Khurshid A. Cancer urinary bladder: 5 years experience at Cenar, Quetta. J Ayub Med Coll Abbottabad 2001; 13:14-6.
15. Herr HW, Donat SM. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006; 97:1194-8. Epub 2006 Mar 23.
16. Oosterlinck W. The management of superficial bladder. BJU Int 2001; 87:135-40.
17. Sakai I, Miyake H, Harada K, Hara I, Inoue T, Fujisawa M. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ. Int J Urol 2006; 13:1389-92.
18. Herr HW. Natural history of superficial bladder tumours: 10-20 years of follow-up of treated patients. World J Urol 1997; 15:84-8.
19. Akagashi K, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A, et al. Recurrence pattern for superficial bladder cancer. Int J Urol 2006; 13:686-91.
20. Pyrah LN, Raper P, Thomas GM. Report of a follow-up of papillary tumours of the bladder. Br J Med 1964; 36:14-25.
21. Herr HW. Tumour progression and survival of patients with high grade, non-invasive papillary (TaG3) bladder tumours: 15-year outcome. J Urol 2000; 163:60-1; discussion 61-2.
22. Holmong S, Hedelin H, Anderson C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995; 153:1823-6; discussion 1826-7.
23. Cookson MS, Herr Hw, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158:62-7.
24. Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumours? J Urol 2001; 166:1296-9.
25. Thompson RA, Cambell EW, Kramer HC, Jacobs Sc, Naslund MJ. Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol 1993; 149:1010-11.